Skip to content

Medical emergency? What to do

Tip Sheet: Stroke Awareness Month

3-RXPublished March 23, 20064 min read

Key points

  • Stroke experts are studying deadly snake venom and vampire bat saliva to dissolve blood clots in stroke victims.
  • "If either of these drugs can effectively and safely dissolve blood clots and reopen blocked blood vessels, then we may have another weapon against stroke."
  • Julia Gilmore does not know if she received the trial drug or a placebo, but she recovered remarkably well within 24 hours of receiving the medication.
  • Reducing blood flow to the lower half of a person's body may help treat acute ischemic stroke, a blood clot in the brain.

Stroke experts are studying deadly snake venom and vampire bat saliva to dissolve blood clots in stroke victims. One of the trials involves Desmoteplase, a genetically engineered version of a clot-busting agent found in the saliva of a vampire bat that can be given to stroke patients up to nine hours after symptoms appear. The other trial involves Viprinex, an investigational drug derived from a compound found in Malaysian Pit Viper snake venom, called ancrod, which acts as an anti-coagulant in blood. This study may help determine if acute ischemic stroke patients treated with a one-time dose within six hours of the onset of stroke symptoms will have improved neurological function.

"The goal of both experimental drugs is to reduce a naturally occurring substance in the blood that is involved in blood clotting," said Dr. David Chiu, medical director of the Eddy Scurlock Stroke Center at the Methodist Neurological Institute (NI).

"If either of these drugs can effectively and safely dissolve blood clots and reopen blocked blood vessels, then we may have another weapon against stroke."

Investigational neuroprotectant for stroke showing positive signs

The SAINT II clinical trial involving the use of an investigational neuroprotectant, or clot-busting drug, is under way at the Eddy Scurlock Stroke Center. This international randomized, double-blind, placebo-controlled study focuses on NXY-059, or Cerovive, which is shown to be well tolerated in acute ischemic stroke patients up to six hours after onset of stroke symptoms.

Julia Gilmore does not know if she received the trial drug or a placebo, but she recovered remarkably well within 24 hours of receiving the medication. When an air ambulance brought Gilmore to Methodist, she could not speak or walk. The next day, Gilmore could sit up in bed, speak and lift her arms. She was discharged less than a week later.

Dr. David Chiu, medical director of the Eddy Scurlock Stroke Center at the Methodist NI, is also looking at Cerovive's benefits as a possible treatment for hemorrhagic stroke, when a blood vessel in the brain ruptures.

Investigational NeuroFlo device for ischemic stroke

Reducing blood flow to the lower half of a person's body may help treat acute ischemic stroke, a blood clot in the brain. Dr. Richard Klucznik, medical director of the Texas Neurovascular Center at the Methodist NI, is using an investigational device called the NeuroFlo Catheter in ischemic stroke patients.

This investigational device uses a catheter inserted into the leg and guided to the lower aorta. The device has two balloons, each of which is inflated to decrease blood flow to the lower body, which may allow more blood to flow to the brain. The purpose of the study is to determine if an increase of blood flow to the brain will reduce the damage caused by stroke. The study, which began with 18 U.S. patients, has now expanded to include up to 500 patients at 40 U.S. locations.

Interventional stroke treatment uses first FDA-approved brain stent

A stent made specifically for the brain now helps doctors treat stroke patients in a way never done before. For years, cardiac stents were often used, but these devices were not specifically approved for the brain and were less effective.

The Wingspan Stent is the first FDA-approved brain stent designed specifically for the brain's fragile vessels and allows physicians the maneuverability to handle the twists and turns to place the stent in an artery and open the blockage, according to Dr. Richard Klucznik, medical director of the Texas Neurovascular Center. Once deployed, the metal mesh opens to form the shape of a tube, forcing the artery to re-open, and reestablishing blood flow.

Implanted pump targets spasticity in stroke patients

An implantable device the size of a hockey puck is changing lives in stroke patients who suffer from spasticity. The Intrathecal Baclofen Pump (ITB), implanted in the abdomen, continuously delivers the drug Baclofen directly to the spine and can reduce involuntary, abnormal muscle movement common to patients who have suffered a stroke.

Dr. Stanley Fisher, neurologist at the Methodist NI, says patients often experience side effects when taking Baclofen orally. By injecting the drug into the spinal cord, the patient receives a smaller, continuous dose of concentrated medication without the unwanted side effects. The pump is a lightweight, refillable device that holds up to 90 days supply of Baclofen, a drug that is known to help control spasticity.

http://www.methodistneuroinstitute.com

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underStroke

Keep reading

Stroke

Useful stroke trials left unpublished

An investigation into unpublished stroke research data has revealed that 19.6% of completed clinical trials, which could potentially influence patient care, are not published in full. Researchers writing in BioMed…

3 min read

Trauma

Different strokes help tissue heal

Using simple handheld tools, physical therapist Laurie Eickhoff carefully rubs patient Lisa Maharry's leg to treat her Achilles injury with a new therapy intended to stimulate the body's normal healing process.…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.